Literature DB >> 31214537

Vitamin D and its Relation to Bone Mineral Density in Postmenopause Women.

Pedro José Labronici1, Saulo Santos Blunck2, Flavius Ribeiro Lana2, Bruno Bandeira Esteves2, José Sergio Franco3, Junji Miller Fukuyama4, Robinson Esteves Santos Pires5.   

Abstract

OBJECTIVE: Compare the level of vitamin D with the bone mineral density (BMD) in postmenopausal women, with or without fractures.
METHODS: 250 women with mean age of 71.1 were evaluated. The serum levels of vitamin D considered sufficient were ≥ 30 ng/mL, insufficient between 20 and 30 ng/mL and deficient < 20 ng/mL. The bone mineral density was measured and considered osteopenia when T value total of lumbar spine or hip was between -1 and -2.5 and osteoporosis < 2.5. The patients with fractures accounted for 25.2%.
RESULTS: There was no significant difference in the vitamin D (ng/mL) levels among the age groups (p = 0.25), the levels of fractures (p = 0.79) and the levels of BMD (p = 0.76).
CONCLUSION: 82% of the patients presented deficient and insufficient blood levels of vitamin D. Ours results showed any significant correlation between vitamin D levels and bone mineral density after adjusting for age.

Entities:  

Keywords:  Bone density; Fractures bone; Osteoporosis; Vitamin D

Year:  2013        PMID: 31214537      PMCID: PMC6565868          DOI: 10.1016/j.rboe.2012.07.003

Source DB:  PubMed          Journal:  Rev Bras Ortop        ISSN: 2255-4971


Introduction

The loss of bone density in postmenopausal women has been linked to a subclinical deficiency in vitamin D, which is considered to be a risk factor for fractures due to the susceptibility of this population to falls and inappropriate neuromuscular responses.1, 2, 3, 4 Vitamin D insufficiency can result from nutritional deficiency and/or low sun exposure in confined elderly patients and inpatients with chronic diseases.5, 6, 7, 8 Studies have shown that female patients who ingest high levels of calcium exhibit high bone mineral density when compared to female patients with low calcium ingestion. Vitamin D and calcium supplements aid in the prevention of bone loss by reducing bone renewal and the number of non- vertebral fractures. Supplemental vitamin D and calcium (500-1,200 mg/d) seems to reduce the risk of secondary hyperparathyroidism due to vitamin D insufficiency. Vitamin D is absorbed through two mechanisms: the activation of the 7-dehydrocholesterol pathway in the skin by sunlight and the intestinal absorption of the vitamin D in food. The appropriate serum level of vitamin D is approximately 30 to 55 ng/mL. Values below 20 ng/mL are considered to be deficient and levels in the 20 to 30 ng/mL range are considered inappropriate.11, 12 The objective of this paper was to compare the vitamin D levels and BMD of postmenopausal women with or without fractures.

Materials and Methods

Two hundred fifty women with a mean age of 71.1 years old (45 to 98) were evaluated between January 2010 and December 2011. The included patients were postmenopausal women who had reached menopause two years before and had received a bone densitometry scan at least six months prior to the initial visit. The women underwent analysis to determine their vitamin D level and were not using a corticosteroid. The serum vitamin D levels were measured by electrochemiluminescence; values ≥ 30 ng/mL were considered normal, values between 20 and 30 ng/mL were considered insufficient and values < 20 ng/mL were considered deficient. The patients’ BMD in the region of the hips and the lumbar spine was measured with GER's Lunar Prodigy Advance Densitometer with fan bean technology. The hip densitometry measurement included the trochanter, the femur neck and the intertrochanteric region. The lumbar spine densitometry measurement included the lumbar vertebrae L1- L4. The included software calculated the T and Z values relative to North-American reference values. Osteopenia was defined as a T-score between -1 and -2.5 at the lumbar spine or hips and osteoporosis was defined as a T-score < -2.5. The sample characterization was aimed at developing a general profile of the 250 female patients studied. Table 1 shows the mean, the standard deviation (SD), the median, and the minimum and maximum numeric variables. Table 2 provides the frequency (n) and the percentage (%) of the categorical variables.
Table 1

General Description of Numeric Variables.

VariableMeanSDMedianMinimumMaximum
Age (years)71.110.3714598
Vitamin D2.810.521.85.780.9
Spine BMD-1.41.4-1.5-4.63.7
Femur BMD*-1.31.2-1.3-5.42

SD: Standard Deviation. * corresponds to the lower BMD value in the bilateral cases. Source: Hospital Santa Teresa, Petrópolis, RJ.

Table 2

General Description of Categorical Variables.

VariableCategoryn%
Age (years)45 to 4941.6
50 to 592811.2
60 to 697630.4
70 to 798935.6
80 to 894518
90 to 9983.2
Fractureyes6325.2
no18774.8
Vitamin D (classification)209437.6
21 to 2911144.4
304518
BMD (classification)normal5823.2
osteopenia11445.6
7831.2

Source: Hospital Santa Teresa, Petrópolis, RJ.

General Description of Numeric Variables. SD: Standard Deviation. * corresponds to the lower BMD value in the bilateral cases. Source: Hospital Santa Teresa, Petrópolis, RJ. General Description of Categorical Variables. Source: Hospital Santa Teresa, Petrópolis, RJ.

Statistical Methodology

The tables summarize the data observed, which were expressed as the frequency (n) and percentage (%) for categorical (qualitative) data and as the mean, standard deviation, median and the minimum and maximum for numeric data. The statistical analysis consisted of the following methods: the numeric variables for two subgroups were compared using the Student's t test for independent samples or the Mann-Whitney test; comparisons among three subgroups were analyzed using a one-way ANOVA or the Kruskal- Wallis Anova test (non-parametric). Tukey's or Dunn's multiple comparison tests (non-parametric) were applied to identify which groups were significantly different from each other at the level of 5%, and the categorical variables for the subgroups were compared using the χ2 test. Non-parametric tests were applied because some variables did not present a normal distribution (Gaussian); due to data dispersion, the null hypothesis was rejected according to the Kolmogorov-Smirnov test. Significance was defined at the level of 5%. SAS 6.11 (SAS Institute, Inc., Cary, North Carolina, USA) software was used to complete the statistical analysis.

Results

The first objective was to verify if there were significant differences between fracture status (present or not), vitamin D level (deficient, insufficient and sufficient) and BMD (normal, osteopenia and osteoporosis) with relation to the mean age of the patients (in years). Table 3 summarizes the mean ± standard deviation (SD) of the patients’ age based on the fracture status, vitamin D level and BMD and the corresponding p values calculated by the appropriate statistical test.
Table 3

Mean patient age (years) for each of the fracture, vitamin D3 and BMD categories.

SubgroupCategorynMean ± SDp valuea
Fractureyes6375.3 ± 11.50.0002
no18769.7 ± 9.5
BMD (classification)normal5868.4 ± 10.40.0001
osteopenia11469.6 ± 9.7
osteoporosis7875.3 ± 10.0
Vitamin D (classification)deficiency9472.6 ± 10.50.13
insufficient11169.7 ± 9.6
sufficient4571.5 ± 11.3

Student's t test for independent samples or one-way Anova.

Mean patient age (years) for each of the fracture, vitamin D3 and BMD categories. Student's t test for independent samples or one-way Anova. The statistical analysis utilized the Student's t test for independent samples to compare two categories (levels) or the one-way Anova to compare three categories. Tukey's multiple comparison test was used to identify which categories were significantly different from each other at a level of 5%. The mean age of the subgroup of patients with fractures was significantly higher than the mean age of the subgroup without fractures (p = 0.0002). The mean ages of the patients with differing BMD levels were also significantly different (p = 0.0001). The mean age of the subgroup of patients with osteoporosis was significantly higher than the mean ages of the subgroups with normal BMD and osteopenia. There was no significant difference in the mean age of patients with different vitamin D levels (p = 0.13). The second objective was to verify if there was significant difference in the vitamin D levels (in ng/mL) of the patients with different ages, fracture statuses and BMD levels. Table 4 summarizes the median, the minimum and maximum vitamin D levels (ng/mL) for each age group (45 to 59, 60 to 69, 70 to 79 and 80 to 99 years old), fracture status (present or not) and BMD level (normal, osteopenia and osteoporosis) and the corresponding p value of the statistical test used for the comparison.
Table 4

Vitamin D level (ng/mL) for each age group, fracture status and BMD category.

VariableCategorynMedianMinimumMaximump valuea
Age (years)45 to 593221.714.156.90.25
60 to 697622.29.764.7
70 to 798920.8980.9
80 to 995322.65.772
Fractureyes6322.15.7720.79
no18721.66.280.9
BMD (classification)normal5821.29.364.70.76
osteopenia11421.9952.4
osteoporosis7822.25.780.9

Mann-Whitney test or Kruskal-Wallis Anova. Source: Hospital Santa Teresa. Petrópolis. RJ.

Vitamin D level (ng/mL) for each age group, fracture status and BMD category. Mann-Whitney test or Kruskal-Wallis Anova. Source: Hospital Santa Teresa. Petrópolis. RJ. The statistical analysis utilized the Mann-Whitney test to compare two categories (levels) or the Kruskal-Wallis Anova to compare three categories. Dunn's multiple comparison test was used to identify which categories were significantly different from each other at a level of 5%. There were no significant differences in the vitamin D levels (ng/mL) among the age groups (p = 0.25), the fracture status (p = 0.79) or the BMD levels (p = 0.76) (Fig. 1).
Fig. 1

Relationship between vitamin D level and age.

Relationship between vitamin D level and age. The third objective sought to identify whether there was significant association among the following variables: age group, fracture status, vitamin D level and BMD. Table 5, Table 6, Table 7, Table 8 provide the frequency (n) and the percentage (%) of the contingency tables for the four variables studied and the corresponding p value of the χ2 test. The analyses were repeated and are only presented if the results differed.
Table 5

Association between each of the variables and age.

VariableCategory45 to 59 years old
60 to 69 years old
70 to 79 years old
80 to 99 years old
p valuea
n%n%n%n%
Fractureyes721.91215.81921.42547.2< 0.0001
no2578.16484.27078.72852.8
Vitamin D (classification)deficiency1031.32634.23943.81935.90.22
insufficient1650.03647.44044.91935.9
sufficient618.81418.41011.21528.3
DMO (classification)normal1237.51925.01921.4815.10.006
osteopenia1546.94052.64146.11834.0
osteoporosis515.61722.42932.62750.9

χ2 test. Source: Hospital Santa Teresa, Petrópolis, RJ.

Table 6

Association between each of the variables and fracture status.

VariableCategoryWith Fracture
Without Fracture
p valuea
n%n%
Age (years)45 to 59711.12513.4< 0.0001
60 to 691219.16434.2
70 to 791930.27037.4
80 to 992539.72815.0
Vitamin D (classification)deficiency2336.57138.00.82
insufficien2742.98444.9
sufficien1320.63217.1
BMD (classification)normal711.15127.30.011
osteopenia2946.08545.5
osteoporosis2742.95127.3

χ2 test. Source: Hospital Santa Teresa, Petrópolis, RJ.

Table 7

Association between each of the variables and vitamin D level.

VariableCategoryDeficient
Insufficient
Sufficient
p valuea
n%n%n%
Age (years)45 to 591010.61614.4613.30.22
60 to 692627.73632.41431.1
70 to 793941.54036.01022.2
80 to 991920.21917.11533.3
Fractureyes2324.52724.31328.90.82
no7175.58475.73271.1
BMD (classification)normal2526.62219.81124.40.77
osteopenia3941.55549.62044.4
osteoporosis3031.93430.61431.1

χ2 test. Source: Hospital Santa Teresa, Petrópolis, RJ.

Table 8

Association between each of the variables and BMD.

VariableCategoryNormal
Osteopenia
Osteoporosis
p valuea
n%n%n%
Age (years)45 to 591220.71513.256.40.006
60 to 691932.84035.11721.8
70 to 791932.84136.02937.2
80 to 99813.81815.82734.6
Fractureyes712.12925.42734.60.011
no5187.98574.65165.4
BMD (classification)deficiency2543.13934.23038.50.77
insufficient2237.95548.33443.6
sufficient1119.02017.51418.0

χ2 test. Source: Hospital Santa Teresa, Petrópolis, RJ.

Association between each of the variables and age. χ2 test. Source: Hospital Santa Teresa, Petrópolis, RJ. Association between each of the variables and fracture status. χ2 test. Source: Hospital Santa Teresa, Petrópolis, RJ. Association between each of the variables and vitamin D level. χ2 test. Source: Hospital Santa Teresa, Petrópolis, RJ. Association between each of the variables and BMD. χ2 test. Source: Hospital Santa Teresa, Petrópolis, RJ. Age group was significantly associated with the presence of fracture (p < 0.0001) and osteoporosis (p = 0.006). The presence of fracture was significantly associated with age group (p < 0.0001) and osteoporosis (p = 0.011). Vitamin D levels were not significantly associated with age group (p = 0.22), fracture (p = 0.82) or BMD (p = 0.77) (Fig. 2).
Fig. 2

Vitamin D levels for each BMD category.

Vitamin D levels for each BMD category. Osteoporosis was significantly associated with age group (p = 0.006) and the presence of fracture (p = 0.011).

Discussion

Vitamin D is extremely important for calcium absorption. When serum vitamin D levels decrease, the parathyroid hormone level increases and calcium absorption decreases. Vitamin D is absorbed through two mechanisms: the acti v ation of the 7-dehydr ocholester ol pathw ay in the skin by sunlight and intestinal absorption from the diet. Although vitamin D deficiency is relatively rare in the healthy young population, this deficiency is common in the elderly population, especially among inpatients or individuals who live in countries where sunlight is limited. It is worth mentioning that vitamin D deficiency is not only limited to the bones or muscles. Recent epidemiological data on vitamin D deficiency have shown an association with arthritis, as well as with non-skeletal diseases such as prostate, colon and breast cancer; diabetes mellitus types 1 and 2; multiple sclerosis; hypertension; cardiovascular disease and schizophrenia.11 This study analyzed the relationship between vitamin D levels and age but did not find any significant difference in the vitamin D levels of different age groups. However, more than 70% of the patients in each of the age groups exhibited deficient or insufficient levels of vitamin D. Therefore, it is advisable to measure serum vitamin D levels at all ages, as deficient and insufficient levels may accelerate bone deterioration and cause osteoporosis. The link between vitamin D and bone mineral density is still being discussed. An evaluation of the vitamin D level in patients with osteoporosis is essential for two reasons. First, vitamin D deficiency in patients with osteoporosis causes demineralization that may reduce bone mass.13, 14 Second, it is important to achieve suitable levels of vitamin D in patients with osteoporosis to maximize the response to antiresorptive therapy, facilitate changes in bone mineral density and efficiently manage fractures. Several studies have sugg ested that low serum vitamin D levels are associated with low bone mineral density.16, 17, 18 Bischoff- Ferrari et al. found a positive relationship between vitamin D levels and bone mineral density in young Caucasians and elderly men. However, other studies have not supported this association.20, 21, 22 The heterogeneity of the results can be partially explained by ethnic differences in the patient populations and differing age groups, as well as by the fact that the studies focused on different regions of the human body. Garnero et al. and Allali et al. were unable to show a significant correlation between vitamin D levels and bone mineral density. Rassouli et al. found a correlation with the bone mineral density of the spine, but not the hips. Sadat-Ali et al. found that most patients with vitamin D insufficiency exhibit low bone mass and that all patients with vitamin D deficiency have bone mineral densities varying between osteopenia and osteoporosis. This group also found a correlation between vitamin D levels and bone mineral density in most patients, particularly those groups exhibiting insufficiency and deficiency. The authors emphasized the importance of measuring vitamin D levels in patients with low bone mass instead of relying only on bone densitometry. Bandeira et al. found vitamin D deficiencies in healthy postmenopausal women of all ages during routine doctor's appointments. The authors concluded that those individuals exhibiting vitamin D levels lower than 25 ng/mL were elderly patients who had reached menopause a long time ago. These patients also exhibited low bone mineral density on the femur neck and high levels of parathyroid hormone. This study indicated that 91.1% of the patients with osteopenia exhibited deficient and insufficient serum vitamin D levels (41.5% and 49.6%, respectively) and that 62.5% of the patients with osteoporosis exhibited deficient and insufficient serum vitamin D levels (31.9% and 30.6%, respectively). However, 46.4% of the normal patients exhibited deficient and insufficient serum vitamin D levels (26.6% and 19.8%, respectively). It is worth mentioning that all of the women in this study were Caucasians from the same reg ion (latitude and altitude). Recent evidence has indicated that sun exposure does not guarantee a healthy vitamin D level. Brinkley et al. evaluated 93 young adults from Hawaii who experienced sun exposure without protection for more than 20 hours per week, finding that 51% of the individuals studied exhibited inappropriate levels of vitamin D (< 30 ng/mL). Because Brazil is a tropical country, the population is expected to have adequate vitamin D levels. However, two studies conducted in elderly patients in the southeastern region of the country (latitude 20-30°S) found a high prevalence of vitamin D deficiency.29, 30, 31, 32 Vitamin D deficiency is present in all regions, but is higher in southern Asia and the Middle East. In our study, we analyzed well nourished Caucasian women who had reached menopause two years before commencement of the study who lived in the same region (22° 30’ 16.70”S latitude, 43° 10’ 56.38”W longitude in a region with a highland tropical climate) in a city lying 838 meters above the sea level. The study results indicated that 37.6% of the patients exhibited deficient serum vitamin D levels. Eighty-two percent of the patients had insufficient and deficient serum vitamin D levels. In the United States of America, the results of the National Health and Nutrition Examination Survey registered deficient vitamin D values in 30% of the patients studied, with 70% of those studied falling into the insufficient and deficient categories. Patton et al. reported that, regardless of the cut-off value, vitamin D levels were relatively low in women when compared with men and low in the Hispanic and Afro- descendant population when compared with the Caucasian population. Hypovitaminosis D has been identified in patients with orthopedic pathologies, especially fractures. Several authors have reported vitamin D insufficiency after orthopedic surgeries, with prevalence varying from 15 to 24%.36, 37 Approximately 80% of patients in an Australian hip fracture study presented with insufficient vitamin D levels, with more than 30% of these patients also exhibiting secondary hyperparathyroidism. Despite the fact that the results of this study were not statistically significant, 42.9% of the patients with fractures exhibited vitamin D insufficiency. It is worth mentioning that this research did not investigate parathyroid hormone levels, which could confound the bone density evaluation (secondary hyperparathyroidism) and lead to osteoporosis in the presence of vitamin D deficiency.

Conclusion

Although this study was carried out in a region with a highland tropical climate, 82% of the patients exhibited deficient or insufficient serum vitamin D levels. Our results did not show a significant correlation between vitamin D levels and bone mineral density according to age.

Conflict of Interest

The authors have no conflict of interests associated with this paper.
  36 in total

1.  Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults.

Authors:  Heike A Bischoff-Ferrari; Thomas Dietrich; E John Orav; Bess Dawson-Hughes
Journal:  Am J Med       Date:  2004-05-01       Impact factor: 4.965

2.  Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study.

Authors:  P Garnero; F Munoz; E Sornay-Rendu; P D Delmas
Journal:  Bone       Date:  2006-11-16       Impact factor: 4.398

3.  The 25-hydroxyvitamin D threshold for better health.

Authors:  Heike A Bischoff-Ferrari
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-16       Impact factor: 4.292

4.  Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D.

Authors:  Robert P Heaney; M Susan Dowell; Cecilia A Hale; Adrianne Bendich
Journal:  J Am Coll Nutr       Date:  2003-04       Impact factor: 3.169

5.  Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.

Authors:  N N Ghannam; M M Hammami; S M Bakheet; B A Khan
Journal:  Calcif Tissue Int       Date:  1999-07       Impact factor: 4.333

6.  Influence of ultraviolet radiation on the production of 25 hydroxyvitamin D in the elderly population in the city of São Paulo (23 degrees 34'S), Brazil.

Authors:  Gabriela Luporini Saraiva; Maysa Seabra Cendoroglo; Luiz Roberto Ramos; Lara Miguel Quirino Araújo; José Gilberto H Vieira; Ilda Kunii; Lillian F Hayashi; Marcelo Paula Corrêa; Marise Lazaretti-Castro
Journal:  Osteoporos Int       Date:  2005-06-10       Impact factor: 4.507

7.  Determination of serum 25-hydroxyvitamin D(3) levels in early postmenopausal Iranian women: relationship with bone mineral density.

Authors:  A Rassouli; I Milanian; M Moslemi-Zadeh
Journal:  Bone       Date:  2001-11       Impact factor: 4.398

8.  Hyperparathyroidism secondary to hypovitaminosis D in hypoalbuminemic is less intense than in normoalbuminemic patients: a prevalence study in medical inpatients in southern Brazil.

Authors:  Melissa Orlandin Premaor; Gustavo Vasconcelos Alves; Ligia Beatriz Crossetti; Tania Weber Furlanetto
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

9.  Differences in vitamin D status between countries in young adults and the elderly.

Authors:  M J McKenna
Journal:  Am J Med       Date:  1992-07       Impact factor: 4.965

10.  Low vitamin D status despite abundant sun exposure.

Authors:  N Binkley; R Novotny; D Krueger; T Kawahara; Y G Daida; G Lensmeyer; B W Hollis; M K Drezner
Journal:  J Clin Endocrinol Metab       Date:  2007-04-10       Impact factor: 5.958

View more
  2 in total

1.  Circulating Serum Amyloid A, hs-CRP and Vitamin D Levels in Postmenopausal Osteoporosis.

Authors:  Anahid Safari; Afshin Borhani-Haghighi; Mehdi Dianatpour; Seyed Taghi Heydari; Farzaneh Foroughinia; Gholamhossein Ranjbar Omrani
Journal:  Galen Med J       Date:  2019-10-09

2.  Association Between Vitamin D and Resistin in Postmenopausal Females With Altered Bone Health.

Authors:  Sundus Tariq; Saba Tariq; Saba Khaliq; Mukhtiar Baig; Manal Abdulaziz Murad; Khalid Parvez Lone
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-15       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.